The Cigna Group Appoints Dr. Amy Flaster Chief Medical Officer
The Cigna Group (NYSE: CI) named Dr. Amy Flaster Chief Medical Officer effective November 1, 2025, expanding her role to lead clinical strategy across Cigna Healthcare and Evernorth. She will focus on clinical excellence, new care models, clinical team growth, and technology to advance whole‑person health, and will report to Brian Evanko.
Katya Andresen, Chief Digital & Analytics Officer, will lead the company’s Excellence & Transformation (XT) initiatives to improve digital, service, and clinical touchpoints. The announcement also notes the departures of Dr. David Brailer (chief health officer) and the retirement of Chris DeRosa after two decades.
The Cigna Group (NYSE: CI) ha nominato la Dott.ssa Amy Flaster Chief Medical Officer con effetto dall'1 novembre 2025, espandendo il suo ruolo per guidare la strategia clinica in Cigna Healthcare ed Evernorth. Si concentrerà sull'eccellenza clinica, su nuovi modelli di assistenza, sulla crescita dei team clinici e sulla tecnologia per avanzare la salute olistica, e riferirà a Brian Evanko.
Katya Andresen, Chief Digital & Analytics Officer, guiderà le iniziative Excellence & Transformation (XT) per migliorare i touchpoint digitali, di servizio e clinici. L'annuncio segnala anche le uscite della Dott.ssa David Brailer (chief health officer) e il pensionamento di dopo due decenni.
The Cigna Group (NYSE: CI) nombra a la Dra. Amy Flaster Chief Medical Officer a partir del 1 de noviembre de 2025, ampliando su función para liderar la estrategia clínica en Cigna Healthcare y Evernorth. Se centrará en la excelencia clínica, nuevos modelos de atención, crecimiento de los equipos clínicos y tecnología para avanzar la salud integral, y reportará a Brian Evanko.
Katya Andresen, Chief Digital & Analytics Officer, dirigirá las iniciativas Excellence & Transformation (XT) de la empresa para mejorar los puntos de contacto digitales, de servicio y clínicos. El anuncio también señala las salidas de la Dra. David Brailer (chief health officer) y la jubilación de Chris DeRosa tras dos décadas.
The Cigna Group (NYSE: CI)는 Dr. Amy Flaster를 Chief Medical Officer로 임명하며 2025년 11월 1일부터 발효되며, 그녀의 역할을 확장해 Cigna Healthcare 및 Evernorth의 임상 전략을 주도합니다. 그녀는 임상 우수성, 새로운 치료 모델, 임상 팀의 성장, 전체 건강 증진을 위한 기술에 집중하고 Brian Evanko에게 보고합니다.
Katya Andresen, Chief Digital & Analytics Officer,는 회사의 Excellence & Transformation (XT) 이니셔티브를 이끌어 디지털, 서비스, 임상 접점의 개선을 목표로 합니다. 또한 발표는 Dr. David Brailer의 이직과 2십년 간의 재임 후 Chris DeRosa의 은퇴도 언급합니다.
The Cigna Group (NYSE: CI) a nommé la Dr. Amy Flaster au poste de Chief Medical Officer, à effet le 1er novembre 2025, élargissant son rôle pour diriger la stratégie clinique à travers Cigna Healthcare et Evernorth. Elle se concentrera sur l'excellence clinique, les nouveaux modèles de soins, la croissance des équipes cliniques et la technologie pour faire progresser la santé globale, et relèvera de Brian Evanko.
Katya Andresen, Chief Digital & Analytics Officer, dirigera les initiatives Excellence & Transformation (XT) de l'entreprise pour améliorer les points de contact numériques, de service et cliniques. L'annonce note également les départs du Dr. David Brailer (chief health officer) et la retraite de Chris DeRosa après deux décennies.
The Cigna Group (NYSE: CI) benannte Dr. Amy Flaster zur Chief Medical Officer mit Wirkung zum 1. November 2025, wodurch sie ihre Rolle erweitert, um die klinische Strategie über Cigna Healthcare und Evernorth zu leiten. Sie wird sich auf klinische Exzellenz, neue Versorgungsmodelle, Wachstum der klinischen Teams und Technologie konzentrieren, um die Ganzheitliche Gesundheit voranzubringen, und an Brian Evanko berichten.
Katya Andresen, Chief Digital & Analytics Officer, wird die Excellence & Transformation (XT)-Initiativen des Unternehmens leiten, um digitale, Service- und klinische Kontaktpunkte zu verbessern. Die Ankündigung vermerkt auch die Abgänge von Dr. David Brailer (Chief Health Officer) und den Rücktritt von Chris DeRosa nach zwei Jahrzehnten.
The Cigna Group (NYSE: CI) عيّنت Dr. Amy Flaster كـ Chief Medical Officer اعتباراً من 1 نوفمبر 2025، موسِّعة دورها لقيادة الاستراتيجية السريرية عبر Cigna Healthcare و Evernorth. ستركّز على التميّز السريري ونماذج الرعاية الجديدة ونمو الفرق السريرية والتقنية لتعزيز الصحة الشاملة، وسترفع تقاريرها إلى Brian Evanko.
Katya Andresen، Chief Digital & Analytics Officer، ستقود مبادرات Excellence & Transformation (XT) لتحسين نقاط الاتصال الرقمية والخدمية والسريرية. كما يشير البيان إلى مغادرة Dr. David Brailer ( chief health officer) وتقاعد Chris DeRosa بعد عقدين.
- Dr. Amy Flaster named enterprise Chief Medical Officer effective Nov 1, 2025
- Dr. Flaster to lead clinical strategy across Cigna Healthcare and Evernorth
- Katya Andresen assigned to lead Excellence & Transformation initiatives
- Dr. Flaster brings clinical and operational experience including MD and MBA
- Dr. David Brailer departs from Executive VP and Chief Health Officer role
- Chris DeRosa retires after more than two decades, reducing senior institutional depth
Chief Digital & Analytics Officer Katya Andresen to lead Excellence & Transformation Initiatives
"Dr. Flaster is a proven strategic and innovative leader with extensive clinical and operational experience in patient care, technology, hospital leadership, and value-based care. In this new role, she will continue our journey to improve the health of millions of patients in partnership with their clinicians," said David M. Cordani, Chairman and Chief Executive Officer, The Cigna Group. "As a practicing primary care physician, Dr. Flaster brings a unique perspective that keeps patients at the heart of every decision, and her deep compassion and unwavering commitment to transforming health care will be invaluable as we advance our commitments to all those we serve."
Since joining Cigna, Dr. Flaster has been a driving force behind several clinical programs that improve health outcomes and affordability for customers and clients. Her leadership has helped shape the organization's approach to integrated care, behavioral health, and digital health innovation. Dr. Flaster will report to Brian Evanko, President and Chief Operating Officer, The Cigna Group.
Prior to joining Cigna Healthcare, Dr. Flaster served as the Chief Medical Officer for ConcertoCare, led the population health team at Health Catalyst, and held hospital leadership roles at Mass General Brigham. She is a practicing primary care physician at Brigham and Women's Hospital in
Katya Andresen to Lead Excellence and Transformation (XT) Initiatives
Katya Andresen, Chief Digital & Analytics Officer, The Cigna Group, is assuming leadership of the organization's Excellence and Transformation (XT) efforts, which are shaping how customers engage with the company, and driving innovation across digital, service, and clinical touchpoints.
The XT initiatives have already driven several actions to improve access to care, including new digital tools to help Cigna Healthcare customers navigate their benefits and medical costs more easily, and implementing protections to lower out-of-pocket costs for Evernorth's pharmacy benefit customers. Under Katya's leadership, the company will continue to advance a more personalized, seamless, and human-centered experience.
Dr. David Brailer Departs After Pivotal Contributions
Dr. Flaster's promotion comes as Dr. David Brailer, who has served as Executive Vice President and Chief Health Officer since 2022, departs the company. Dr. Brailer is a physician recognized for his pioneering leadership in health care, and he brought that same passion to shaping The Cigna Group's enterprise clinical strategy and advancing better access to care and better value of care for the millions of people served by the company.
Chris DeRosa Retires After Two Decades of Impactful Leadership
Chris DeRosa, Head of Business Improvement and Innovation, is retiring after serving more than two decades of impactful leadership at The Cigna Group, including President of
About The Cigna Group
The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions and has more than 186 million customer relationships around the world. Learn more at thecignagroup.com.
Media Contact
Madeline Ziomek
(202) 615-1473
Madeline.ziomek@evernorth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-cigna-group-appoints-dr-amy-flaster-chief-medical-officer-302606060.html
SOURCE The Cigna Group
FAQ
Who is the new Chief Medical Officer of The Cigna Group (CI) and when is it effective?
What responsibilities will Dr. Amy Flaster have as Cigna Group CMO (CI)?
Who will Dr. Amy Flaster report to at The Cigna Group (CI)?
What role will Katya Andresen take on at The Cigna Group (CI)?
Which senior leaders are leaving The Cigna Group (CI) in this announcement?
What clinical background does Dr. Amy Flaster bring to Cigna Group (CI)?
